Date Source Title Access 1 5 May 2019 Hitanshu Dhingra, Adelaide Equity & Partners Ltd A deep dive into Paradigm's OA program and partnering prospects Download PDF 2 23 Jan 2019 Marc Sinatra, Lodge Partners Paradigm Biopharmaceuticals: Mucoplysaccharidosis and what’s to come going forward: BUY Download PDF 3 Nov 25 2018 Fiftyone Capital The Next Australian Blockbuster Biotech Access link 4 5 June 2018 Fiftyone Capital Paradigm Biopharmaceuticals Ltd Research Access link
-
- There are more pages in this discussion • 4,468 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
0.045(11.7%) |
Mkt cap ! $167.4M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 43.5¢ | 37.0¢ | $342.3K | 845.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10002 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 11146 | 1 |
View Market Depth
| Last trade - 11.50am 03/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |